European Medicines Agency (EMA) | What's new Follow Orphan designation: valganciclovir,nanatinostat Treatment of diffuse large B-cell lymphoma, 13/01/2023 Withdrawn https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2742 ema.europa.eu
